AlphaCrest Capital Management’s Zimmer Biomet ZBH Stock Holding History

AlphaCrest Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,949	Closed	-$517K	–	1172
2022 Q3	$517K	Sell	4,949 -15,195	-75%	-$1.67M	0.03%	963
2022 Q2	$2.12M	Buy	20,144 +16,420	+441%	+$1.95M	0.1%	289
2022 Q1	$476K	Sell	3,724 -17,938	-83%	-$2.16M	0.03%	920
2021 Q4	$2.67M	Sell	21,662 -647	-3%	-$84.7K	0.1%	284
2021 Q3	$3.17M	Sell	22,309 -3,444	-13%	-$507K	0.16%	143
2021 Q2	$4.02M	Buy	25,753 +22,912	+806%	+$3.71M	0.17%	159
2021 Q1	$442K	Buy	2,841 +297	+12%	+$46K	0.02%	858
2020 Q4	$381K	Buy	+2,544	New	+$359K	0.03%	800
2020 Q3	–	Sell	-3,514	Closed	-$407K	–	1213
2020 Q2	$407K	Sell	3,514 -3,681	-51%	-$424K	0.07%	473
2020 Q1	$706K	Buy	7,195 +4,885	+211%	+$640K	0.09%	417
2019 Q4	$336K	Sell	2,310 -5,084	-69%	-$702K	0.03%	999
2019 Q3	$985K	Sell	7,394 -23,492	-76%	-$3.03M	0.06%	579
2019 Q2	$3.53M	Buy	+30,886	New	+$3.62M	0.31%	43

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's ZBH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 4,949 shares — an estimated $517K sold.

AlphaCrest Capital Management first reported a position in ZBH in Q2 2019 and held it in 13 quarters. The position peaked at $4.02M in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

AlphaCrest Capital Management reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 4,949 Zimmer Biomet shares in Q4 2022, an estimated $517K.
AlphaCrest Capital Management first reported a position in Zimmer Biomet in Q2 2019 and held it in 13 quarters.
AlphaCrest Capital Management's Zimmer Biomet position peaked at $4.02M in Q2 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.